Sotera Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Sotera Health Company (NASDAQ: SHC), a leading global provider of sterilization solutions, lab testing, and healthcare advisory services, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. Chairman and CEO Michael B. Petras, Jr. will deliver a presentation on Tuesday, January 14, 2025, at 11:15 a.m. Eastern Time.
The company's senior leadership team, including CFO Jon Lyons and VP of Investor Relations Jason Peterson, will engage in investor meetings throughout the conference. Investors and interested parties can access a live webcast of the presentation through Sotera Health's Investor Relations website section under Presentations & Events. The presentation materials will be available for viewing, and a replay will be accessible within 48 hours after the conference concludes.
Sotera Health Company (NASDAQ: SHC), fornitore globale leader di soluzioni di sterilizzazione, testing di laboratorio e servizi di consulenza sanitaria, ha annunciato la sua partecipazione alla 43ª Conferenza Annuale J.P. Morgan Healthcare. Il Chairman e CEO Michael B. Petras, Jr. terrà una presentazione martedì 14 gennaio 2025, alle 11:15 ora orientale.
Il team dirigenziale senior dell'azienda, incluso il CFO Jon Lyons e il VP delle Relazioni con gli Investitori Jason Peterson, parteciperà a incontri con gli investitori durante tutta la conferenza. Gli investitori e le parti interessate possono accedere a una trasmissione in diretta della presentazione attraverso la sezione Relazioni con gli Investitori del sito web di Sotera Health, sotto Presentazioni e Eventi. I materiali della presentazione saranno disponibili per la visualizzazione e una registrazione sarà accessibile entro 48 ore dalla conclusione della conferenza.
Sotera Health Company (NASDAQ: SHC), proveedor global líder de soluciones de esterilización, pruebas de laboratorio y servicios de asesoramiento en salud, ha anunciado su participación en la 43ª Conferencia Anual de J.P. Morgan Healthcare. El presidente y CEO Michael B. Petras, Jr. ofrecerá una presentación el martes 14 de enero de 2025, a las 11:15 a.m. hora del Este.
El equipo de liderazgo senior de la compañía, incluido el CFO Jon Lyons y el VP de Relaciones con Inversores Jason Peterson, participará en reuniones con inversionistas durante toda la conferencia. Los inversionistas y partes interesadas pueden acceder a una transmisión en vivo de la presentación a través de la sección de Relaciones con Inversores en el sitio web de Sotera Health, bajo Presentaciones y Eventos. Los materiales de la presentación estarán disponibles para su visualización, y una repetición estará accesible dentro de las 48 horas posteriores a la conclusión de la conferencia.
소테라 헬스 컴퍼니 (NASDAQ: SHC)는 글로벌 주요 멸균 솔루션 제공업체로, 실험실 테스트 및 헬스케어 자문 서비스를 제공하는 회사입니다. 회사는 제43회 연례 JP모건 헬스케어 컨퍼런스에 참가할 것이라고 발표했습니다. 회장 겸 CEO인 마이클 B. 페트라스 주니어가 2025년 1월 14일 화요일 오전 11시 15분 (동부 표준시)에 발표를 진행합니다.
회사의 고위 리더십 팀, CFO 존 라이온스와 투자자 관계 부사장 제이슨 피터슨을 포함하여, 컨퍼런스 기간 동안 투자자 미팅에 참여할 것입니다. 투자자 및 관심 있는 당사자들은 소테라 헬스의 투자자 관계 웹사이트의 발표 및 이벤트 섹션을 통해 발표의 라이브 웹캐스트에 접속할 수 있습니다. 발표 자료는 조회할 수 있으며, 컨퍼런스 종료 후 48시간 이내에 재생이 가능합니다.
Sotera Health Company (NASDAQ: SHC), un fournisseur mondial leader de solutions de stérilisation, de tests de laboratoire et de services de conseil en santé, a annoncé sa participation à la 43e Conférence Annuelle J.P. Morgan Healthcare. Le président et PDG Michael B. Petras, Jr. présentera une communication le mardi 14 janvier 2025, à 11h15 heure de l'Est.
L'équipe de direction senior de l'entreprise, y compris le CFO Jon Lyons et le VP des Relations Investisseurs Jason Peterson, participera à des réunions avec les investisseurs tout au long de la conférence. Les investisseurs et les parties intéressées peuvent accéder à un webinaire en direct de la présentation via la section Relations Investisseurs du site web de Sotera Health sous Présentations et Événements. Les documents de présentation seront disponibles pour consultation, et une rediffusion sera accessible dans les 48 heures suivant la fin de la conférence.
Sotera Health Company (NASDAQ: SHC), ein weltweit führender Anbieter von Sterilisierungslösungen, Labortests und Beratungsdiensten im Gesundheitswesen, hat seine Teilnahme an der 43. jährlichen J.P. Morgan Healthcare-Konferenz bekannt gegeben. Vorsitzender und CEO Michael B. Petras, Jr. wird am Dienstag, den 14. Januar 2025, um 11:15 Uhr Eastern Time eine Präsentation halten.
Das Führungsteam des Unternehmens, einschließlich CFO Jon Lyons und VP für Investor Relations Jason Peterson, wird während der gesamten Konferenz an Investorenbesprechungen teilnehmen. Investoren und Interessierte können über die Investor-Relations-Website von Sotera Health unter Präsentationen & Veranstaltungen auf einen Live-Stream der Präsentation zugreifen. Die Präsentationsunterlagen werden zur Ansicht verfügbar sein und eine Aufzeichnung wird innerhalb von 48 Stunden nach Ende der Konferenz zugänglich sein.
- None.
- None.
CLEVELAND, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced that Chairman and CEO Michael B. Petras, Jr. will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025 at 11:15 a.m. Eastern Time. Mr. Petras, Jon Lyons, Senior Vice President and CFO, and Jason Peterson, Vice President, Investor Relations and Treasurer, will participate in meetings with investors during the conference.
A live webcast of Mr. Petras’ presentation and accompanying materials may be accessed via the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health. A replay of the webcast will be available within 48 hours following the conclusion of the conference and archived on the Company's website.
About Sotera Health:
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.
Updates can be found from time to time on recent developments in matters relevant to investors on the Investor Relations section of the Company’s website at Investor Relations | Sotera Health. For developments related to Ethylene Oxide, updates can be found at Ethylene Oxide | Sotera Health.
INVESTOR RELATIONS CONTACTS:
Jason Peterson
Vice President, Investor Relations & Treasurer
IR@soterahealth.com
MEDIA CONTACT:
Kristin Gibbs
Chief Marketing Officer
kgibbs@soterahealth.com
Source: Sotera Health Company
FAQ
When is Sotera Health (SHC) presenting at the 2025 J.P. Morgan Healthcare Conference?
How can investors watch Sotera Health's (SHC) J.P. Morgan Healthcare Conference presentation?
Which Sotera Health (SHC) executives will attend the 2025 J.P. Morgan Healthcare Conference?
How long will Sotera Health's (SHC) J.P. Morgan presentation replay be available?
